Abstract
e16207Background: FOLFIRINOX is the standard treatment of patients with metastatic pancreatic cancer. Its effectiveness in the neoadjuvant setting in patients with (borderline) resectable pancreati...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have